Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The fT3/fT4 ratio as a candidate marker of motor progression in SCA3. | Neurobiol Dis | 2026 | 42251968 | PubTator, text mining | PubMed |
| Identifying Genetic Factors Contributing to Non-Syndromic Early-Onset Childhood Obesity Utilizing Whole-Exome Sequencing in Consanguineous Families. | Genes (Basel) | 2026 | 42194987 | PubTator, text mining | PubMed |
| Polyglutamine-Expanded Ataxin-3 Accelerates CFTR Degradation Through K63-Linked Ubiquitination to Exacerbate Microglial Inflammation. | ASN Neuro | 2026 | 42189036 | PubTator, text mining | PubMed |
| Cerebello-Brainstem Dominant Form of X-linked Adrenoleukodystrophy Without Apparent Brain MRI Abnormalities at Disease Onset. | Cerebellum | 2026 | 42105168 | PubTator, text mining | PubMed |
| Identification of FGF14 GAA Expansions in Polish Patients with Undiagnosed Cerebellar Ataxia - A Preliminary Study. | Cerebellum | 2026 | 42096001 | PubTator, text mining | PubMed |
| A Whole-Exome Sequencing-Based Exploration of Chronic Kidney Disease of Unknown Etiology (CKDu) in an Endemic Population in Sri Lanka. | Int J Mol Sci | 2026 | 42074016 | PubTator, text mining | PubMed |
| Characterization of T-Cell Ubiquitination in Melanoma and Development of a Risk Signature Using Single-Cell and Bulk RNA-Seq. | Immunology | 2026 | 42012139 | PubTator, text mining | PubMed |
| The relationship between level of education and disease onset and progression in spinocerebellar ataxia types 1, 2, 3, and 6. | Parkinsonism Relat Disord | 2026 | 41996746 | PubTator, text mining | PubMed |
| Thioxanthone-Mediated Cytoprotection Against Cisplatin Toxicity: Exploring the Potential Involvement of P-Glycoprotein Through Computational and Experimental Approaches. | J Xenobiot | 2026 | 41874126 | PubTator, text mining | PubMed |
| Clinical and genetic diagnostic challenges in presumed hereditary ataxia. | J Neurol | 2026 | 41870659 | PubTator, text mining | PubMed |
| Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias. | Cerebellum | 2026 | 41866445 | PubTator, text mining | PubMed |
| Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3. | Hum Mol Genet | 2026 | 41854058 | PubTator, text mining | PubMed |
| Childhood-Onset Huntington's Disease-Like Presentation of SCA17 with Intermediate Repeats, A Case Report. | Cerebellum | 2026 | 41843312 | PubTator, text mining | PubMed |
| Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3. | Biomaterials | 2026 | 41830765 | PubTator, text mining | PubMed |
| Exploring the Potential of Scales to Assess Different Types of Ataxia: Meta-review. | Cerebellum | 2026 | 41824138 | PubTator, text mining | PubMed |
| Retrotransposition Events Shape the Evolution of the Ataxin-3 Gene Family in Primates. | Genome Biol Evol | 2026 | 41818480 | PubTator, text mining | PubMed |
| ORMDL Proteins Turnover via Proteasome and Autophagy Is Cell-Type Dependent and Tied to Ceramide Homeostasis. | FASEB J | 2026 | 41806112 | PubTator, text mining | PubMed |
| Selective silencing of expanded CAG repeats: Chemically modified siRNA advances RNA-based therapies for polyglutamine diseases. | Mol Ther Nucleic Acids | 2026 | 41783786 | PubTator, text mining | PubMed |
| Metformin improves RAN protein pathology, alternative splicing, and behavioral phenotypes in SCA8 mice. | Life Sci Alliance | 2026 | 41771688 | PubTator, text mining | PubMed |
| Short tandem repeat expansions in patients with neurodegenerative dementia. | EBioMedicine | 2026 | 41762523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=2